Literature DB >> 23523330

Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.

Gabriella M Anic1, Vernon K Sondak, Jane L Messina, Neil A Fenske, Jonathan S Zager, Basil S Cherpelis, Ji-Hyun Lee, William J Fulp, Pearlie K Epling-Burnette, Jong Y Park, Dana E Rollison.   

Abstract

BACKGROUND: Telomeres help maintain chromosomal structure and may influence tumorigenesis. We examined the association between telomere length and skin cancer in a clinic-based case-control study of 198 melanoma cases, 136 squamous cell carcinoma (SCC) cases, 185 basal cell carcinoma (BCC) cases, and 372 healthy controls.
METHODS: Cases were histologically confirmed patients treated at the Moffitt Cancer Center and University of South Florida Dermatology Clinic in Tampa, FL. Controls self-reported no history of cancer and underwent a skin cancer screening exam at study enrollment to rule out the presence of skin cancer. Quantitative real time PCR was used to measure telomere length in peripheral blood samples.
RESULTS: Melanoma patients had longer telomeres than controls (odds ratio (OR)=3.75; 95% confidence interval (CI): 2.02-6.94 for highest versus lowest tertile) (P for trend=<0.0001). In contrast, longer telomere length was significantly inversely associated with SCC (OR=0.01; 95% CI: 0.00-0.05 for highest versus lowest tertile) (P for trend=<0.0001) and BCC (OR=0.10; 95% CI: 0.06-0.19 for highest versus lowest tertile) (P for trend=<0.0001).
CONCLUSION: Telomere length may be involved in the development of skin cancer, although the effect on cancer risk differs for melanoma and non-melanoma carcinomas. Our findings suggest that long telomere length is positively associated with melanoma while inversely associated with SCC and BCC.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23523330      PMCID: PMC3679277          DOI: 10.1016/j.canep.2013.02.010

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  26 in total

1.  Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population.

Authors:  Xiaonan Liu; Guoqiang Bao; Tingting Huo; Zizhong Wang; Xianli He; Guanglong Dong
Journal:  Cancer Sci       Date:  2009-04-30       Impact factor: 6.716

2.  Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls.

Authors:  Maria M Gramatges; Melinda L Telli; Raymond Balise; James M Ford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

3.  No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer.

Authors:  Geyu Liang; Abrar A Qureshi; Qun Guo; Immaculata De Vivo; Jiali Han
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-25       Impact factor: 4.254

Review 4.  Implementing personalized medicine in a cancer center.

Authors:  David A Fenstermacher; Robert M Wenham; Dana E Rollison; William S Dalton
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

5.  Telomere length and variation in telomere biology genes in individuals with osteosarcoma.

Authors:  Lisa Mirabello; Elliott G Richards; Linh M Duong; Kai Yu; Zhaoming Wang; Richard Cawthon; Sonja I Berndt; Laurie Burdett; Salma Chowdhury; Kedest Teshome; Chester Douglass; Sharon A Savage
Journal:  Int J Mol Epidemiol Genet       Date:  2010-11-23

6.  Telomere length in different tissues of elderly patients.

Authors:  U Friedrich; E Griese; M Schwab; P Fritz; K Thon; U Klotz
Journal:  Mech Ageing Dev       Date:  2000-11-15       Impact factor: 5.432

Review 7.  Role of telomeres and telomerase in genomic instability, senescence and cancer.

Authors:  Yibin Deng; Sandy Chang
Journal:  Lab Invest       Date:  2007-09-03       Impact factor: 5.662

8.  A prospective study of telomere length and the risk of skin cancer.

Authors:  Jiali Han; Abrar A Qureshi; Jennifer Prescott; Qun Guo; Li Ye; David J Hunter; Immaculata De Vivo
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

9.  Telomere length is associated with obesity parameters but with a gender difference.

Authors:  Katarina Nordfjäll; Mats Eliasson; Birgitta Stegmayr; Olle Melander; Peter Nilsson; Göran Roos
Journal:  Obesity (Silver Spring)       Date:  2008-09-25       Impact factor: 5.002

10.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.

Authors:  David C Whiteman; Peter Watt; David M Purdie; Maria Celia Hughes; Nicholas K Hayward; Adèle C Green
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

View more
  32 in total

Review 1.  Telomeres in Interstitial Lung Disease: The Short and the Long of It.

Authors:  Andrew M Courtwright; Souheil El-Chemaly
Journal:  Ann Am Thorac Soc       Date:  2019-02

2.  A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.

Authors:  Huiling He; Wei Li; Daniel F Comiskey; Sandya Liyanarachchi; Taina T Nieminen; Yanqiang Wang; Katherine E DeLap; Pamela Brock; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-02       Impact factor: 6.568

3.  Processed Meat, but Not Unprocessed Red Meat, Is Inversely Associated with Leukocyte Telomere Length in the Strong Heart Family Study.

Authors:  Amanda M Fretts; Barbara V Howard; David S Siscovick; Lyle G Best; Shirley Aa Beresford; Mihriye Mete; Sigal Eilat-Adar; Nona Sotoodehnia; Jinying Zhao
Journal:  J Nutr       Date:  2016-08-24       Impact factor: 4.798

4.  Shorter telomere length in Europeans than in Africans due to polygenetic adaptation.

Authors:  Matthew E B Hansen; Steven C Hunt; Rivka C Stone; Kent Horvath; Utz Herbig; Alessia Ranciaro; Jibril Hirbo; William Beggs; Alexander P Reiner; James G Wilson; Masayuki Kimura; Immaculata De Vivo; Maxine M Chen; Jeremy D Kark; Daniel Levy; Thomas Nyambo; Sarah A Tishkoff; Abraham Aviv
Journal:  Hum Mol Genet       Date:  2016-03-02       Impact factor: 6.150

5.  Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians.

Authors:  Beatriz Sanchez-Espiridion; Meng Chen; Joe Y Chang; Charles Lu; David W Chang; Jack A Roth; Xifeng Wu; Jian Gu
Journal:  Cancer Res       Date:  2014-03-11       Impact factor: 12.701

6.  Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.

Authors:  Ekta Khattar; Pavanish Kumar; Chia Yi Liu; Semih Can Akıncılar; Anandhkumar Raju; Manikandan Lakshmanan; Julien Jean Pierre Maury; Yu Qiang; Shang Li; Ern Yu Tan; Kam M Hui; Ming Shi; Yuin Han Loh; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

Review 7.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

8.  Leukocyte Telomere Length in Newborns: Implications for the Role of Telomeres in Human Disease.

Authors:  Pam Factor-Litvak; Ezra Susser; Katrina Kezios; Ian McKeague; Jeremy D Kark; Matthew Hoffman; Masayuki Kimura; Ronald Wapner; Abraham Aviv
Journal:  Pediatrics       Date:  2016-03-11       Impact factor: 7.124

9.  Telomere length dynamics in early life: the blood-and-muscle model.

Authors:  Sanjeev Sabharwal; Simon Verhulst; George Guirguis; Jeremy D Kark; Carlos Labat; Natalie E Roche; Kristina Martimucci; Krunal Patel; Debra S Heller; Masayuki Kimura; Donald Chuang; Anne Chuang; Athanase Benetos; Abraham Aviv
Journal:  FASEB J       Date:  2017-08-29       Impact factor: 5.191

10.  Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.

Authors:  Da-Tian Bau; Scott M Lippman; Enping Xu; Yilei Gong; J Jack Lee; Xifeng Wu; Jian Gu
Journal:  Cancer       Date:  2013-09-16       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.